Robert Sundel, MD
Rheumatologist, Rheumatology Program; Fred S. Rosen Chair in Pediatric Rheumatology
Associate Professor of Pediatrics, Harvard Medical School
Image
Robert Sundel, MD
Rheumatologist, Rheumatology Program; Fred S. Rosen Chair in Pediatric Rheumatology
Associate Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Hebrew
Education
Medical School
Boston University School of Medicine
1982
Boston
MA
Internship
Babies Hospital
1983
New York
NY
Residency
Babies Hospital
1985
New York
NY
Fellowship
Boston Children's Hospital
1989
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Rheumatology)
Publications
Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab Treatment. View Abstract
Implications of Inflammatory Processes on a Developing Central Nervous System in Childhood-Onset Systemic Lupus Erythematosus. View Abstract
Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders. View Abstract
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome. View Abstract
Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic-Exposed Children With Systemic Juvenile Idiopathic Arthritis. View Abstract
Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. View Abstract
An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. View Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. View Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. View Abstract
Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis. View Abstract
Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. View Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. View Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. View Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. View Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. View Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. View Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. View Abstract
A multidisciplinary assessment of pain in juvenile idiopathic arthritis. View Abstract
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms. View Abstract
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. View Abstract
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. View Abstract
Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. View Abstract
Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. View Abstract
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. View Abstract
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. View Abstract
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. View Abstract
Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. View Abstract
Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. View Abstract
Posterior-onset Rasmussen's encephalitis with ipsilateral cerebellar atrophy and uveitis resistant to rituximab. View Abstract
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. View Abstract
Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. View Abstract
Pediatric CNS-isolated hemophagocytic lymphohistiocytosis. View Abstract
Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. View Abstract
Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2. View Abstract
Association Between Dose of Glucocorticoids and Coronary Artery Lesions in Kawasaki Disease. View Abstract
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America. View Abstract
Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores. View Abstract
National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA. View Abstract
Evidence-based decision support for pediatric rheumatology reduces diagnostic errors. View Abstract
Clarifying the Role of Corticosteroids in Kawasaki Disease. View Abstract
Kawasaki Disease at 50 Years. View Abstract
Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA. View Abstract
Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis. View Abstract
Kawasaki disease. View Abstract
Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management. View Abstract
Pain hypersensitivity in juvenile idiopathic arthritis: a quantitative sensory testing study. View Abstract
Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors. View Abstract
A119: deep sequencing analysis of the T regulatory and T effector repertoire in juvenile idiopathic arthritis. View Abstract
Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study. View Abstract
Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease. View Abstract
Pediatric chronic nonbacterial osteomyelitis. View Abstract
Paediatric rheumatic disease: Classification warfare. View Abstract
Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. View Abstract
Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial. View Abstract
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. View Abstract
Putting collagen back in the collagen vascular disorders. View Abstract
Primary lyme arthritis of the pediatric hip. View Abstract
Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. View Abstract
Musculoskeletal causes of pediatric chest pain. View Abstract
Outcomes of children treated for Lyme arthritis: results of a large pediatric cohort. View Abstract
Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. View Abstract
Atypical and incomplete Kawasaki disease. View Abstract
Editorial: Do no harm--first but not only. View Abstract
Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. View Abstract
Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment. View Abstract
MRI findings of juvenile psoriatic arthritis. View Abstract
Chronic minocycline-induced autoimmunity in children. View Abstract
Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis. View Abstract
Delayed diagnosis of Kawasaki disease: what are the risk factors? View Abstract
Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. View Abstract
Vasculitis in children. View Abstract
Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. View Abstract
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. View Abstract
Gene-expression patterns reveal underlying biological processes in Kawasaki disease. View Abstract
Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. View Abstract
Patients with juvenile psoriatic arthritis comprise two distinct populations. View Abstract
Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. View Abstract
MRI features of Lyme arthritis in children. View Abstract
Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. View Abstract
Vasculitis in children. View Abstract
Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study. View Abstract
Rituximab therapy for multisystem autoimmune diseases in pediatric patients. View Abstract
A clinical practice guideline for treatment of septic arthritis in children: efficacy in improving process of care and effect on outcome of septic arthritis of the hip. View Abstract
Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. View Abstract
Raynaud's phenomenon in children: a retrospective review of 123 patients. View Abstract
Physical and psychosocial health in children who have had Kawasaki disease. View Abstract
Update on the treatment of Kawasaki disease in childhood. View Abstract
Fibroblastic rheumatism: case report and review of the literature. View Abstract
Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. View Abstract
Vasculitis in childhood. View Abstract
Prolonged sensory and motor deficit following short-term lumbar epidural analgesia in a patient with mixed connective tissue disease. View Abstract
Vasculitis in childhood. View Abstract
Treatment of TRAPS with etanercept: use in pediatrics. View Abstract
Aortic root dilation in Kawasaki disease. View Abstract
Psoriatic eruption in Kawasaki disease. View Abstract
Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease. View Abstract
Report of the National Institutes of Health Workshop on Kawasaki Disease. View Abstract
Outcomes of children treated for Lyme disease. View Abstract
Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. View Abstract
Coronary artery dimensions may be misclassified as normal in Kawasaki disease. View Abstract
A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. View Abstract
Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group. View Abstract
Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. View Abstract
Osteomyelitis and septic arthritis in children: appropriate use of imaging to guide treatment. View Abstract
Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor. View Abstract
Kawasaki disease and its cardiac sequelae. View Abstract
Kawasaki disease and acute renal failure. View Abstract
Gamma globulin re-treatment in Kawasaki disease. View Abstract
Audiologic profiles of children with Kawasaki disease. View Abstract
Decreased protein binding of salicylates in Kawasaki disease. View Abstract
Sensorineural hearing loss associated with Kawasaki disease. View Abstract
Kawasaki disease. View Abstract